Monica Eimunjeze Becomes Acting DG of NAFDAC



Dr Monica Eimunjeze

Dr Monica Eimunjeze , has been appointed as the acting director general of the National Agency for Food and Drug, Administration and Control, NAFDAC.

Her appointment comes as the former DG, Prof. Mojisola Adeyeye, is said to have commenced her retirement leave.

In an internal memo dated 17 November, 2022, Augustine Oboli, an assistant director, said the management is in receipt of a letter appointing Eimunjeze as acting director-general.

Oboli, who copied 27 directors in the memo, said Eimunjeze’s appointment took effect from November 12.

He said “The management is in receipt of a letter appointing Dr Monica Eimunjeze as the acting director-general of NAFDAC with effect from 12th November 2022,” the letter reads.

Study Shows Evidence That Fat Can Accumulate in Lungs

“I am therefore directed to bring this development to you for information and guidance.”

Eimunjeze is a pharmacist of repute who graduated from the Ahmadu Bello University (ABU), Zaria, with a bachelor’s degree in Pharmacy in 1986 and obtained a doctorate in Pharmacy from Mercer University, Georgia, USA.

Until her appointment, Eimunjeze was the agency’s director of registration and regulatory affairs.

Before then, she served as the technical assistant to the director-general of NAFDAC and as the director, drug evaluation and research.

Dr Eimunjeze has coordinated several national and international programmes to support and  strengthen regulatory capacity within the agency, as well as worked on several projects to institute regulatory reform.

Merck Diabetes and Hypertension Awards to be rolled out in African and Asian Universities as part of Merck Capacity Advancement Program

She has represented the agency and made presentations at several fora highlighting the agency’s activities and achievements.



  1. Congratulations Dr. Monica Eimunjeze FPSN for a well deserved appointment. Wishing her success on the job.


Please enter your comment!
Please enter your name here